Sofia Vasilakaki
6PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 24, 2022
The discovery and development of transmembrane serine protease 2 (TMPRSS2) inhibitors as candidate drugs for the treatment of COVID-19.Christiana Mantzourani, Sofia Vasilakaki, Velisaria-Eleni Gerogianni
|Jun 18, 2021
The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases.Charikleia S Batsika, Anna-Dimitra D Gerogiannopoulou, Christiana Mantzourani
|Mar 06, 2021
α-Ketoheterocycles Able to Inhibit the Generation of Prostaglandin E2 (PGE2) in Rat Mesangial Cells.Anastasia Psarra, Maria A Theodoropoulou, Martin Erhardt
|Jan 13, 2021
Inflammatory Mediators and Pain in Endometriosis: A Systematic Review.Nikolaos Machairiotis, Sofia Vasilakaki, Nikolaos Thomakos
|Feb 23, 2020
Hydration thermodynamics of cytosolic phospholipase A2 GIVA predict its membrane-associated parts and its highly hydrated binding site.Sofia Vasilakaki, Johannes Kraml, Michael Schauperl
|Nov 10, 2017
Using physics-based pose predictions and free energy perturbation calculations to predict binding poses and relative binding affinities for FXR ligands in the D3R Grand Challenge 2.Christina Athanasiou, Sofia Vasilakaki, Dimitris Dellis
Pageof 1
Frequent Collaborators
4 joint publications
George Kokotos
1 joint publications
Christina Athanasiou
1 joint publications
Zoe Cournia
1 joint publications
Johannes Kraml
1 joint publications
Klaus R Liedl
1 joint publications
Nikolaos Machairiotis
1 joint publications
Maria A Theodoropoulou
1 joint publications
Andrea Huwiler
1 joint publications
Christiana Mantzourani
